Anton P. Zhiyanov
Moscow, MOW, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Targetome profile of hsa-miR-93-5p is resistant to isoform formation in prostate adenocarcinoma.
Journal: PeerJ
Published: July 16, 2025
CD44 knockdown alters miRNA expression and their target genes in colon cancer.
Journal: Frontiers in immunology
Published: December 28, 2024
Autoantigenic peptide landscape of rheumatoid arthritis-associated HLA class II.
Journal: Genes & diseases
Published: August 12, 2024
Incautious design of shRNAs for stable overexpression of miRNAs could result in generation of undesired isomiRs.
Journal: Biochimica et biophysica acta. Gene regulatory mechanisms
Published: November 17, 2023
Intracellular Gemcitabine Monophosphate Levels Predict Chemotherapy Efficacy in Gemcitabine-Treated Patients with Bladder Cancer.
Journal: Doklady. Biochemistry and biophysics
Published: May 20, 2023
The signature of SARS-CoV-2 evolution reflects selective pressures within human guts.
Journal: Journal of medical virology
Published: April 06, 2023
SARS-CoV-2 Mutations Lead to a Decrease in the Number of Tissue-Specific MicroRNA-Binding Regions in the Lung.
Journal: Bulletin of experimental biology and medicine
Published: November 02, 2022
A novel approach for a joint analysis of isomiR and mRNA expression data reveals features of isomiR targeting in breast cancer.
Journal: Frontiers in genetics
Published: October 15, 2022
Differences in Presentation of SARS-CoV-2 Omicron Strain Variant BA.1-BA.5 Peptides by HLA Molecules.
Journal: Doklady. Biochemistry and biophysics
Published: September 01, 2022
isomiRTar: a comprehensive portal of pan-cancer 5'-isomiR targeting.
Journal: PeerJ
Published: July 28, 2022
Differential co-expression network analysis with DCoNA reveals isomiR targeting aberrations in prostate cancer.
Journal: Bioinformatics (Oxford, England)
Published: July 04, 2022
Last Updated: 09/26/2026